Residential Substance Use Disorder Treatment Act of 2023

To amend the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize the residential substance use disorder treatment program, and for other purposes. 1. Short title This Act may be cited as the Residential Substance Use Disorder Treatment Act of 2023 2. Residential substance use disorder treatment program (a) Amendments Part S of title I of the Omnibus Crime Control and Safe Streets Act of 1968 ( 34 U.S.C. 10421 et seq. (1) in the part heading, by striking substance abuse substance use disorder (2) in section 1901 ( 34 U.S.C. 10421 (A) in subsection (a)— (i) in paragraph (1)— (I) by striking substance abuse substance use disorder (II) by inserting after programs , including medication-assisted treatment programs, which shall be permitted to use any type of medication that has been approved to treat substance use disorders pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 42 U.S.C. 262 (ii) in paragraph (3), by striking substance abuse substance use disorder (B) in subsection (b), by striking substance abuse substance use disorder (C) in subsection (c)— (i) by striking part for treatment (1) treatment ; (ii) in paragraph (1), as so designated, by striking the period at the end and inserting ; and (iii) by adding at the end the following: (2) expanding residential substance use disorder treatment programs to use not less than 1 medication or treatment that has been approved to treat substance use disorders pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ; (3) in section 1902 ( 34 U.S.C. 10422 (A) in subsection (b)— (i) in the subsection heading, by striking abuse use (ii) by striking substance abuse substance use disorder (B) in subsection (c), by striking substance abuse substance use disorder (C) in subsection (d), by striking substance abuse treatment substance use disorder treatment (D) in subsection (f), by striking substance abuse substance use disorder (E) by adding at the end the following: (g) Training requirement (1) In general To be eligible to receive funds under this part, the chief medical officer of the prison or jail or appropriate staff overseeing the program shall complete training, before or within a reasonable amount of time after receiving the funds, on, at a minimum— (A) the science of addiction; (B) the latest research and clinical guidance for detoxification and withdrawal management and the treatment of substance use disorders in criminal justice settings; (C) strategies for continuity of care during and after incarceration; (D) an overview of— (i) all medications for the treatment of substance use disorders; (ii) how to obtain certification as an opioid treatment provider (OTP) or waivers under the Controlled Substances Act ( 21 U.S.C. 801 et seq. (iii) evidence-based behavioral therapies used in addition to medication to improve medication adherence and treatment outcomes; and (E) any other topic determined by the Attorney General, in coordination with the Secretary of Health and Human Services and in consultation with experts in addiction science, to be a core element for successful training under this paragraph. (2) Requirement The training required under paragraph (1) shall include guidance on how to— (A) engage relevant stakeholders; (B) identify available resources for, and gaps and barriers to, providing residential substance use disorder treatment; and (C) develop a plan to overcome obstacles to administering and offering medication-assisted treatment. (h) Provider affiliation Any entity, including a prison or jail, that receives Federal funds for a program or activity that offers medication-assisted treatment shall have an affiliation with a provider that can— (1) prescribe not less than 1 medication-assisted treatment to patients after release from the entity; and (2) discuss the risks and benefits of, and alternatives to, medication-assisted treatment with patients. ; and (4) in section 1904 ( 34 U.S.C. 10424 (A) by amending subsection (c) to read as follows: (c) Local allocation (1) In general Not less than 10 percent of the total amount made available to a State under subsection (a) for any fiscal year shall be used by the State to make grants to local correctional and detention facilities in the State (provided such facilities exist therein). (2) Jail-based substance use treatment programs A jail-based substance use disorder treatment program described in paragraph (1) may be made available to any individual who is— (A) awaiting trial or is otherwise in pre-trial detention; or (B) serving a sentence of imprisonment in the jail. ; and (B) by amending subsection (d) to read as follows: (d) Evidence-Based treatments (1) In general A State may use amounts received under this part to— (A) provide any type of medication-assisted treatment that has been approved to treat substance use disorders pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 42 U.S.C. 262 (B) cover costs associated with the training required under section 1902(g); (C) obtain waivers under clause (ii) or (iv) of section 303(g)(2)(G) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G) (D) obtain certification as an opioid treatment provider (OTP) in accordance with part 8 of title 42, Code of Federal Regulations, or any successor thereto, or the prescription of medications to treat substance use disorders. (2) Definition In this subsection, the term medication-assisted treatment 21 U.S.C. 355 42 U.S.C. 262 . (b) Authorization of appropriations Section 1001(a)(17) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 ( 34 U.S.C. 10261(a)(17) (17) There are authorized to be appropriated to carry out the projects under part S $40,000,000 for each of fiscal years 2023 through 2027. . (c) Definition Section 901(25) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 ( 34 U.S.C. 10251(25) (25) the term residential substance use disorder treatment program Promising Practice Guidelines for Residential Substance Abuse Treatment .

Summary: Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.